RecruitingNCT02445534

Registry of Cell Therapy in Non-Ischemic Dilated Cardiomyopathy

Sponsor

University Medical Centre Ljubljana

Enrollment

250 participants

Start Date

Jan 1, 2005

Study Type

OBSERVATIONAL

Conditions

Cardiomyopathy, Dilated

Summary

Although several studies have demonstrated beneficial effects of stem cell therapy in patients with non-ischemic dilated cardiomyopathy, the long term benefits and predictors of response to therapy remain undefined. The aim of this registry is to pool long-term clinical data in patients with non-ischemic dilated cardiomyopathy undergoing autologous cell therapy in an attempt to better define predictors of response to such treatment.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Exclusion Criteria1

Patients with acute multi-organ failure or a history of hematologic neoplasms were not included.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALAutologous stem cell therapy

All patients received granulocyte-colony stimulating factor (G-CSF; 5 mg/kg, 5 days). CD34+ cell were then collected by apheresis and injected transendocardially or intracororonary.